Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks

Trial ID or NCT#

NCT01615731

Status

not recruiting iconNOT RECRUITING

Purpose

A common practice for preparation for surgical abortion after 19 weeks gestation is the placement of multiple sets of osmostic dilators 1-2 days prior to the procedure. The investigators aim to study the addition of mifepristone as an adjunct to cervical dilation prior to abortion between 19-24 weeks gestation, and its potential to minimize the number of painful procedures and time in clinic (or away from work/home) that multiple sets of dilators can require. The investigators hypothesize that one set of dilators with mifepristone will result in similar procedure times and decreased "total" time as two sets of dilators.

Official Title

Value of Mifepristone in Eliminating the Need for a Second Set of Osmotic Dilators Prior to Dilation and Evacuation Between 19-24 Weeks: A Randomized Trial

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * \>18 years old* Viable, Singleton pregnancy* Voluntarily seeking abortion between 19 and 24wks gestation* Able to give informed consent and comply with study protocol* Fluent in English or Spanish
Exclusion Criteria:
  1. * Allergy to misoprostol or mifepristone
View All Criteria
Show Less

Investigator(s)

Paul D. Blumenthal, MD, MPH
Paul D. Blumenthal, MD, MPH
Obstetrician and Gynecologist (OB-GYN), Family planning specialist
Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus

Contact us to find out if this trial is right for you.

Contact

Kate A Shaw, MD

View on ClinicalTrials.gov